Gábor Rácz

Gábor Rácz

Auto-generated profile, based on publicly available information

Gábor Rácz

Metabolic and Newborn Screening Laboratory, Department of Paediatrics, University of Szeged

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Chromatography A
Verified
Journal Article
Closed access
ZGZsolt Galla
Zsolt Galla
CRCecilia Rajda
Cecilia Rajda
GRGábor Rácz
Gábor Rácz
NGNóra Grecsó
Nóra Grecsó
ÁBÁkos Baráth
Ákos Baráth
PMPéter Monostori
Péter Monostori

8 May 2004 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
Boel De PaepeBoel De Paepe
Boel De Paepe
GRGabor Z. Racz
Gabor Z. Racz
JSJ. Michael Schröder
J. Michael Schröder
JBJan L. De Bleecker
Jan L. De Bleecker

1 December 2017 in Orvosi Hetilap
Verified
Journal Article
Open access
FPFerenc Papp
Ferenc Papp
GRGábor Rácz
Gábor Rácz
ILIstván Lénárt
István Lénárt
JKJenő Kóbor
Jenő Kóbor
CBCsaba Bereczki
Csaba Bereczki
ÁBÁkos Baráth
Ákos Baráth
Introduction: Infant vitamin B12 deficiency can manifest as a severe neurodegenerative disorder and is usually caused by maternal deficiency due to vegetarian diet or pernicious anaemia. Its early recognition and treatment can prevent potentially serious and irreversible neurologic damage. Biochemically, vitamin B12 deficiency leads to an accumulation of methylmalonic acid, homocysteine, and propionylcarnitine. Expanded newborn screening using tandem mass spectrometry may identify neonatal and maternal vitamin B12 deficiency by measurement of propionylcarnitine and other metabolites in the dried blood spot sample of newborns. Aim: To summarize our experiences gained by screening for vitamin B12 deficiency. Method: Clinical and laboratory data of vitamin B12-deficient infants diagnosed in Szeged Screening Centre were retrospectively analysed. Results: In Hungary, expanded newborn screening was introduced in 2007. Since then approximately 395 000 newborns were screened in our centre and among them, we identified four newborns with vitamin B12 deficiency based on their screening results. In three cases an elevated propionylcarnitine level and in the fourth one a low methionine level were indicative of vitamin B12 deficiency. We also detected an additional vitamin B12-deficient infant with neurological symptoms at 4 months of age, after a normal newborn screening, because of elevated urinary methylmalonic acid concentration. Vitamin B12 deficiency was secondary to maternal autoimmune pernicious anaemia in all the five infants. As a result of the recognized cases the incidence of infant vitamin B12 deficiency in the East-Hungarian region was 1.26/100 000 births, but the real frequency may be higher. Conslusions: Optimizing the cut off values of current screening parameters and measuring of methylmalonic acid and/or homocysteine in the dried blood spot, as a second tier test, can improve recognition rate of vitamin B12 deficiency. Orv Hetil. 2017; 158(48): 1909–1918.